Certain Semiconductors and Devices and Products Containing the Same, Including Printed Circuit Boards, Automotive Parts, and Automobiles; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety Based on Withdrawal of the Complaint, 13468-13469 [2023-04355]

Download as PDF 13468 Federal Register / Vol. 88, No. 42 / Friday, March 3, 2023 / Notices INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1348] Certain Cabinet X-Ray and Optical Camera Systems and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation Based on Consent Order Stipulations; Issuance of Consent Orders; Termination of the Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 4) of the presiding Chief Administrative Law Judge (‘‘CALJ’’) terminating the investigation based on consent order stipulations. The Commission has entered consent orders against respondents CompAI Healthcare (Shenzhen) Co., Ltd., CompAI Healthcare (Suzhou) Co., Ltd., Kangpai Medical Technology (Changchun) Co., Ltd., Kangpai (Beijing) Medical Equipment Co., Ltd., and Dilon Technologies, Inc. The investigation is terminated. SUMMARY: ddrumheller on DSK120RN23PROD with NOTICES1 FOR FURTHER INFORMATION CONTACT: Michael Liberman, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2392. Copies of non-confidential documents filed in connection with this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: On January 3, 2023, the Commission instituted this investigation under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, based on a complaint filed by KUB Technologies, Inc. of Stratford, Connecticut. 88 FR 113–14 (Jan. 3, 2023). The complaint alleged a violation of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain cabinet x-ray and optical camera VerDate Sep<11>2014 19:33 Mar 02, 2023 Jkt 259001 systems and components thereof by reason of infringement of certain claims of U.S. Patent No. 10,670,545. Id. at 113. The complaint also alleged the existence of a domestic industry. The notice of investigation named as respondents the following entities: CompAI Healthcare (Shenzhen) Co., Ltd. of Shenzhen, Guangdong, China (‘‘CompAI Shenzhen’’), CompAI Healthcare (Suzhou) Co., Ltd. of Suzhou, Jiangsu, China (‘‘CompAI Suzhou’’), Kangpai Medical Technology (Changchun) Co., Ltd. of Suzhou, Jiangsu, China (‘‘Kangpai Changchun’’), Kangpai (Beijing) Medical Equipment Co., Ltd. of Suzhou, Jiangsu, China (‘‘Kangpai Beijing’’), and Dilon Technologies, Inc. of Newport News, Virginia (‘‘Dilon’’) (collectively, ‘‘Respondents’’). Id. at 114. The Commission’s Office of Unfair Import Investigations is not a party to this investigation. Id. On January 11, 2023, all of the Respondents in this investigation— CompAI Shenzhen, CompAI Suzhou, Kangpai Changchun, Kangpai Beijing, and Dilon—filed a motion to terminate this investigation based on consent orders and a memorandum in support thereof. (‘‘Mot.’’). The motion indicates that it is unopposed. See id. at 1. On January 31, 2023, the CALJ issued the subject ID (Order No. 4) granting the motion. The ID found that the Respondents represent that ‘‘there are no other agreements, written or oral, express or implied between the parties concerning the subject matter of the investigation.’’ ID at 1 (citing Mot. at 2; 19 CFR 210.21(c)). The ID found that, consistent with Commission Rule 210.21(c)(1)(ii), each of the Respondents provided a consent order stipulation and proposed consent order with the pending motion. Id. at 2– 4. With respect to each of the Respondents, the ID found that their respective consent order stipulations and respective proposed consent orders conform with Commission Rules 210.21(c)(3) and 210.21(c)(4), respectively. Id. Based on the motion papers and the record as a whole, the ID found that any effect the proposed consent orders may have on the statutory public interest factors does not counsel against entry of the order. Id. at 5. In addition, the ID found that termination of the investigation as to the Respondents by consent order will preserve Commission resources and avoid unnecessary litigation. Id. The Commission has determined not to review the subject ID and to issue consent orders against respondents CompAI Healthcare (Shenzhen) Co., PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Ltd., CompAI Healthcare (Suzhou) Co., Ltd., Kangpai Medical Technology (Changchun) Co., Ltd., Kangpai (Beijing) Medical Equipment Co., Ltd., and Dilon Technologies, Inc. Accordingly, the investigation is terminated in its entirety. The Commission vote for this determination took place on February 27, 2023. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, and in Part 210 of the Commission’s Rules of Practice and Procedure, 19 CFR part 210. By order of the Commission. Issued: February 27, 2023. Katherine Hiner, Supervisory Attorney. [FR Doc. 2023–04356 Filed 3–2–23; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Inv. No. 337–TA–1332] Certain Semiconductors and Devices and Products Containing the Same, Including Printed Circuit Boards, Automotive Parts, and Automobiles; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety Based on Withdrawal of the Complaint U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review the presiding administrative law judge’s (‘‘ALJ’’) initial determination (‘‘ID’’) (Order No. 16), granting complainant’s motion to terminate the investigation based on withdrawal of the complaint as to all respondents. The investigation is terminated in its entirety. FOR FURTHER INFORMATION CONTACT: Cathy Chen, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone 202– 205–2392. Copies of non-confidential documents filed in connection with this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its SUMMARY: E:\FR\FM\03MRN1.SGM 03MRN1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 88, No. 42 / Friday, March 3, 2023 / Notices internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on October 14, 2022, based on a complaint filed on behalf of Daedalus Prime LLC of Bronxville, NY (‘‘Complainant’’). 87 FR 62454 (Oct. 14, 2022).1 The complaint, as supplemented, alleged violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain semiconductors and devices and products containing the same, including printed circuit boards, automotive parts, and automobiles by reason of infringement of one or more of claims 1–18 of U.S. Patent No. 8,775,833 (‘‘the ’833 patent’’); claims 1–18 of U.S. Patent No. 8,898,494 (‘‘the ’494 patent’’); claims 1–17 of the ’895 patent; claims 1–24 of U.S. Patent No. 10,049,080 (‘‘the ’080 patent’’); claims 1–19 of U.S. Patent No. 10,394,300 (‘‘the ’300 patent’’); and claims 1–20 of U.S. Patent No. 10,705,588 (‘‘the ’588 patent’’). Id. at 62454–55. The complaint further alleged that an industry in the United States exists. Id. The notice of investigation named as respondents: Avnet, Inc. of Phoenix, AZ; Digi-Key Electronics of Thief River Falls, MN; Mercedes-Benz Group AG and Mercedes-Benz AG, both of Germany; Mercedes-Benz USA, LLC of Sandy Springs, GA; Mouser Electronics, Inc. of Mansfield, TX; Newark of Chicago, IL; NXP Semiconductors N.V. of Netherlands; and NXP USA, Inc. of Austin, TX (collectively, ‘‘Respondents’’). Id. at 62455. The Office of Unfair Import Investigations (‘‘OUII’’) is also participating in this investigation. Id. Claims 6, 8, 10, 16, and 17 of the ’300 patent, claims 6, 11, and 12 of the ’833 patent, claims 8–12 and 16 of the ’494 patent, claims 2, 4–5, 12–13, and 20 of the ’588 patent, claims 9–16, 21, and 22 of the ’080 patent, and all asserted claims of the ’895 patent have been terminated from the investigation. See Order No. 11 (Dec. 13, 2022), unreviewed by Comm’n Notice (Jan. 11, 2023); Order No. 13 (Jan. 3, 2023), 1 A Corrected Notice of Institution was published on November 2, 2022. 87 FR 66208 (Nov. 2, 2022). The Corrected Notice of Institution omits the determination on whether an industry ‘‘is in the process of being established’’ from the investigation. Id. at 66209. VerDate Sep<11>2014 19:33 Mar 02, 2023 Jkt 259001 unreviewed by Comm’n Notice (Jan. 30, 2023). On January 20, 2023, Complainant filed a motion to withdraw the complaint as to all Respondents. Respondents did not oppose the motion and OUII filed a response supporting the motion. On January 30, 2023, the ALJ issued the subject ID (Order No. 16), granting Complainant’s motion to terminate the investigation in its entirety based on withdrawal of the complaint. The ID found that the motion complies with Commission Rule 210.21(a)(1), 19 CFR 210.21(a)(1), and there are no extraordinary circumstances preventing termination of the investigation. See ID at 2. No petition for review of the ID was filed. The Commission has determined not to review the subject ID. The investigation is terminated in its entirety. The Commission vote for this determination took place on February 24, 2023. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, and in Part 210 of the Commission’s Rules of Practice and Procedure, 19 CFR part 210. By order of the Commission. Issued: February 27, 2023. Katherine M. Hiner, Supervisory Attorney. [FR Doc. 2023–04355 Filed 3–2–23; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE [OMB Number 1117–0014] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Currently Approved Collection; Application for Registration and Application for Registration Renewal; DEA Forms 224, 224A Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until May 2, 2023. SUMMARY: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 13469 If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776–3882. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. FOR FURTHER INFORMATION CONTACT: Overview of This Information Collection 1. Type of Information Collection: Revision of a currently approved collection. 2. Title of the Form/Collection: Application for Registration and Application for Registration Renewal. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Forms: 224, 224A. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): Not-for-profit institutions; Federal, State, local, and tribal governments. Abstract: The Controlled Substances Act (CSA) (21 U.S.C. 801–971) requires E:\FR\FM\03MRN1.SGM 03MRN1

Agencies

[Federal Register Volume 88, Number 42 (Friday, March 3, 2023)]
[Notices]
[Pages 13468-13469]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04355]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Inv. No. 337-TA-1332]


Certain Semiconductors and Devices and Products Containing the 
Same, Including Printed Circuit Boards, Automotive Parts, and 
Automobiles; Notice of a Commission Determination Not To Review an 
Initial Determination Terminating the Investigation in Its Entirety 
Based on Withdrawal of the Complaint

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review the presiding administrative 
law judge's (``ALJ'') initial determination (``ID'') (Order No. 16), 
granting complainant's motion to terminate the investigation based on 
withdrawal of the complaint as to all respondents. The investigation is 
terminated in its entirety.

FOR FURTHER INFORMATION CONTACT: Cathy Chen, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone 202-205-2392. Copies of non-
confidential documents filed in connection with this investigation may 
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email 
[email protected]. General information concerning the Commission may 
also be obtained by accessing its

[[Page 13469]]

internet server at https://www.usitc.gov. Hearing-impaired persons are 
advised that information on this matter can be obtained by contacting 
the Commission's TDD terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on October 14, 2022, based on a complaint filed on behalf of Daedalus 
Prime LLC of Bronxville, NY (``Complainant''). 87 FR 62454 (Oct. 14, 
2022).\1\ The complaint, as supplemented, alleged violations of section 
337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, based upon 
the importation into the United States, the sale for importation, and 
the sale within the United States after importation of certain 
semiconductors and devices and products containing the same, including 
printed circuit boards, automotive parts, and automobiles by reason of 
infringement of one or more of claims 1-18 of U.S. Patent No. 8,775,833 
(``the '833 patent''); claims 1-18 of U.S. Patent No. 8,898,494 (``the 
'494 patent''); claims 1-17 of the '895 patent; claims 1-24 of U.S. 
Patent No. 10,049,080 (``the '080 patent''); claims 1-19 of U.S. Patent 
No. 10,394,300 (``the '300 patent''); and claims 1-20 of U.S. Patent 
No. 10,705,588 (``the '588 patent''). Id. at 62454-55. The complaint 
further alleged that an industry in the United States exists. Id. The 
notice of investigation named as respondents: Avnet, Inc. of Phoenix, 
AZ; Digi-Key Electronics of Thief River Falls, MN; Mercedes-Benz Group 
AG and Mercedes-Benz AG, both of Germany; Mercedes-Benz USA, LLC of 
Sandy Springs, GA; Mouser Electronics, Inc. of Mansfield, TX; Newark of 
Chicago, IL; NXP Semiconductors N.V. of Netherlands; and NXP USA, Inc. 
of Austin, TX (collectively, ``Respondents''). Id. at 62455. The Office 
of Unfair Import Investigations (``OUII'') is also participating in 
this investigation. Id.
---------------------------------------------------------------------------

    \1\ A Corrected Notice of Institution was published on November 
2, 2022. 87 FR 66208 (Nov. 2, 2022). The Corrected Notice of 
Institution omits the determination on whether an industry ``is in 
the process of being established'' from the investigation. Id. at 
66209.
---------------------------------------------------------------------------

    Claims 6, 8, 10, 16, and 17 of the '300 patent, claims 6, 11, and 
12 of the '833 patent, claims 8-12 and 16 of the '494 patent, claims 2, 
4-5, 12-13, and 20 of the '588 patent, claims 9-16, 21, and 22 of the 
'080 patent, and all asserted claims of the '895 patent have been 
terminated from the investigation. See Order No. 11 (Dec. 13, 2022), 
unreviewed by Comm'n Notice (Jan. 11, 2023); Order No. 13 (Jan. 3, 
2023), unreviewed by Comm'n Notice (Jan. 30, 2023).
    On January 20, 2023, Complainant filed a motion to withdraw the 
complaint as to all Respondents. Respondents did not oppose the motion 
and OUII filed a response supporting the motion.
    On January 30, 2023, the ALJ issued the subject ID (Order No. 16), 
granting Complainant's motion to terminate the investigation in its 
entirety based on withdrawal of the complaint. The ID found that the 
motion complies with Commission Rule 210.21(a)(1), 19 CFR 210.21(a)(1), 
and there are no extraordinary circumstances preventing termination of 
the investigation. See ID at 2. No petition for review of the ID was 
filed.
    The Commission has determined not to review the subject ID. The 
investigation is terminated in its entirety.
    The Commission vote for this determination took place on February 
24, 2023.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, and 
in Part 210 of the Commission's Rules of Practice and Procedure, 19 CFR 
part 210.

    By order of the Commission.

    Issued: February 27, 2023.
Katherine M. Hiner,
Supervisory Attorney.
[FR Doc. 2023-04355 Filed 3-2-23; 8:45 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.